Reduction of Antitumor Immunity Caused by Asbestos Exposure

[1]  G. Fontanini,et al.  Surgery for malignant pleural mesothelioma: an international guidelines review. , 2018, Journal of thoracic disease.

[2]  T. Otsuki,et al.  Inflammatory Alteration of Human T Cells Exposed Continuously to Asbestos , 2018, International journal of molecular sciences.

[3]  E. Taioli,et al.  Review of malignant pleural mesothelioma survival after talc pleurodesis or surgery. , 2017, Journal of thoracic disease.

[4]  W. Hwang,et al.  The Synthetic Lignan Secoisolariciresinol Diglucoside Prevents Asbestos-Induced NLRP3 Inflammasome Activation in Murine Macrophages , 2017, Oxidative medicine and cellular longevity.

[5]  M. Krstic-Demonacos,et al.  Promising investigational drug candidates in phase I and phase II clinical trials for mesothelioma , 2017, Expert opinion on investigational drugs.

[6]  H. Matsuzaki,et al.  Accelerated cell cycle progression of human regulatory T cell-like cell line caused by continuous exposure to asbestos fibers , 2016, International journal of oncology.

[7]  Nick A Maskell,et al.  Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment , 2016, European Respiratory Review.

[8]  H. Matsuzaki,et al.  The Suppressed Induction of Human Mature Cytotoxic T Lymphocytes Caused by Asbestos Is Not due to Interleukin-2 Insufficiency , 2016, Journal of immunology research.

[9]  Roberto Würth,et al.  Molecular Pharmacology of Malignant Pleural Mesothelioma: Challenges and Perspectives From Preclinical and Clinical Studies. , 2016, Current drug targets.

[10]  H. Matsuzaki,et al.  FoxO1 regulates apoptosis induced by asbestos in the MT-2 human T-cell line , 2016, Journal of immunotoxicology.

[11]  M. Sayan,et al.  The NLRP3 inflammasome in pathogenic particle and fibre-associated lung inflammation and diseases , 2015, Particle and Fibre Toxicology.

[12]  H. Matsuzaki,et al.  Environmental factors and human health: fibrous and particulate substance-induced immunological disorders and construction of a health-promoting living environment , 2016, Environmental Health and Preventive Medicine.

[13]  H. Matsuzaki,et al.  Enhancement of regulatory T cell-like suppressive function in MT-2 by long-term and low-dose exposure to asbestos. , 2015, Toxicology.

[14]  S. Toyokuni,et al.  Malignant mesothelioma as an oxidative stress-induced cancer: An update. , 2015, Free radical biology & medicine.

[15]  Yitao Wang,et al.  Characterization of MT-2 cells as a human regulatory T cell-like cell line , 2014, Cellular and Molecular Immunology.

[16]  S. Toyokuni,et al.  Asbestos and multi-walled carbon nanotubes generate distinct oxidative responses in inflammatory cells , 2014, Journal of clinical biochemistry and nutrition.

[17]  H. Matsuzaki,et al.  Chronic exposure to asbestos enhances TGF-β1 production in the human adult T cell leukemia virus-immortalized T cell line MT-2. , 2014, International journal of oncology.

[18]  Takemi Otsuki,et al.  Functional Properties of CD8+ Lymphocytes in Patients with Pleural Plaque and Malignant Mesothelioma , 2014, Journal of immunology research.

[19]  M. Birrell,et al.  The role of the inflammasome in fibrotic respiratory diseases. , 2014, Minerva medica.

[20]  H. Matsuzaki,et al.  Alteration of cytoskeletal molecules in a human T cell line caused by continuous exposure to chrysotile asbestos. , 2013, Immunobiology.

[21]  H. Matsuzaki,et al.  Effect of asbestos exposure on differentiation of cytotoxic T lymphocytes in mixed lymphocyte reaction of human peripheral blood mononuclear cells. , 2013, American journal of respiratory cell and molecular biology.

[22]  Takashi Takahashi,et al.  Iron overload signature in chrysotile‐induced malignant mesothelioma , 2012, The Journal of pathology.

[23]  H. Matsuzaki,et al.  Resistance to asbestos-induced apoptosis with continuous exposure to crocidolite on a human T cell. , 2012, The Science of the total environment.

[24]  H. Matsuzaki,et al.  Asbestos-Induced Cellular and Molecular Alteration of Immunocompetent Cells and Their Relationship with Chronic Inflammation and Carcinogenesis , 2012, Journal of biomedicine & biotechnology.

[25]  T. Otsuki,et al.  Decreased CXCR3 expression in CD4+ T cells exposed to asbestos or derived from asbestos-exposed patients. , 2011, American journal of respiratory cell and molecular biology.

[26]  T. Otsuki,et al.  Reduction of CXC chemokine receptor 3 in an in vitro model of continuous exposure to asbestos in a human T-cell line, MT-2. , 2011, American journal of respiratory cell and molecular biology.

[27]  Per Axel Clausen,et al.  Long, needle-like carbon nanotubes and asbestos activate the NLRP3 inflammasome through a similar mechanism. , 2011, ACS nano.

[28]  A. Musk,et al.  Asbestos‐related disease , 2011, Internal medicine journal.

[29]  S. Toyokuni,et al.  [Mechanisms of asbestos-induced carcinogenesis]. , 2011, Nihon eiseigaku zasshi. Japanese journal of hygiene.

[30]  T. Sporn.  Mineralogy of asbestos. , 2011, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[31]  D. A. Dorsey,et al.  Benign asbestos-related pleural disease. , 2011, Disease-a-month : DM.

[32]  T. Otsuki,et al.  Dysregulation of the immune system caused by silica and asbestos , 2010, Journal of immunotoxicology.

[33]  D. Kamp,et al.  Molecular mechanisms of asbestos-induced lung epithelial cell apoptosis. , 2010, Chemico-biological interactions.

[34]  J. Tschopp,et al.  Nanoparticles activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause pulmonary inflammation through release of IL-1α and IL-1β , 2010, Proceedings of the National Academy of Sciences.

[35]  A. Gualtieri,et al.  Biological effects and comparative cytotoxicity of thermal transformed asbestos-containing materials in a human alveolar epithelial cell line. , 2010, Toxicology in vitro : an international journal published in association with BIBRA.

[36]  R. Attanoos.  Asbestos-Related Lung Disease. , 2010, Surgical pathology clinics.

[37]  T. Otsuki,et al.  Decrease in Phosphorylation of ERK following Decreased Expression of NK Cell-Activating Receptors in Human NK Cell Line Exposed to Asbestos , 2009, International journal of immunopathology and pharmacology.

[38]  T. Nakano,et al.  Impairment in Cytotoxicity and Expression of NK Cell- Activating Receptors on Human NK Cells following Exposure to Asbestos Fibers , 2009, International journal of immunopathology and pharmacology.

[39]  D. Kamp,et al.  Asbestos-induced lung diseases: an update. , 2009, Translational research : the journal of laboratory and clinical medicine.

[40]  T. Saga,et al.  Potential role of ferritin heavy chain in oxidative stress and apoptosis in human mesothelial and mesothelioma cells: implications for asbestos-induced oncogenesis. , 2007, Carcinogenesis.

[41]  T. Nakano,et al.  Involvement of IL-10 and Bcl-2 in resistance against an asbestos-induced apoptosis of T cells , 2006, Apoptosis.

[42]  K. Sugamura,et al.  Regulatory T cell-like activity of Foxp3+ adult T cell leukemia cells. , 2006, International immunology.

[43]  Y. Matsuo,et al.  Inhibitory Effects of Anti‐Oxidants on Apoptosis of a Human Polyclonal T‐Cell Line, MT‐2, Induced by an Asbestos, Chrysotile‐A , 2005, Scandinavian journal of immunology.

[44]  I. Poser,et al.  Modulation of genotoxic effects in asbestos-exposed primary human mesothelial cells by radical scavengers, metal chelators and a glutathione precursor. , 2004, Mutation research.

[45]  S. Weitzman,et al.  Asbestos causes apoptosis in alveolar epithelial cells: role of iron-induced free radicals. , 2001, The Journal of laboratory and clinical medicine.

[46]  W. Nicholson,et al.  The carcinogenicity of chrysotile asbestos--a review. , 2001, Industrial health.

[47]  W. Nicholson,et al.  The hazards of chrysotile asbestos: a critical review. , 1999, Industrial health.

[48]  A. Frank,et al.  Carcinogenic implications of the lack of tremolite in UICC reference chrysotile. , 1998, American journal of industrial medicine.

[49]  A. Smith,et al.  Chrysotile asbestos is the main cause of pleural mesothelioma. , 1996, American journal of industrial medicine.

[50]  J. Harington,et al.  The Carcinogenicity of Chrysotile Asbestos , 1991, Annals of the New York Academy of Sciences.